Laser illumination platform with real-time spectral monitoring and treatment

Presented in: SPIE BIOS 2022

Authors: Visa Kaivosoja, Robert Perttilä, Elias Kokko, Timo Tanila, Zoe Ylöniemi, Petteri Uusimaa, Modulight Corporation (Finland)

Personalized medicine is one of the main directions in current cancer care. To support this trend, Modulight has designed a laser illumination platform with real-time spectral monitoring to adjust treatments based on each patient’s optical properties of the tissue, providing more personalization to light-based treatments. The laser has been designed to illuminate and retrieve spectral data from the tumor tissue simultaneously from up to eight different locations. The medical laser is cloud-connected, and all diagnostic data is downloaded in real time into the analytics server to assist in the personalized treatment decisions. This enables machine learning and AI-based data analytics to process recorded data to make more informed treatment decisions and deliver the best treatment outcomes to patients. The laser with this optical monitoring feature is currently being evaluated in glioblastoma trials where illumination can be tailored through spectral monitoring of the fluorescent drug and optical properties of the treated tissue.

 

 

Read the article here